ZNF625 activators are a category of chemical agents developed to specifically enhance the functional activity of the ZNF625 protein, a member of the zinc finger protein family. ZNF625, like other zinc finger proteins, likely plays a role in DNA binding and transcriptional regulation due to the presence of zinc finger motifs-characteristic structural elements that stabilize protein domains responsible for interacting with DNA or RNA molecules. These motifs are typically composed of a combination of cysteine and histidine residues that coordinate a zinc ion, contributing to the tertiary structure necessary for binding to nucleic acids or proteins. ZNF625 activators, therefore, are designed to influence the structural conformation of ZNF625 or its interaction with other molecular entities in such a way as to boost its regulatory influence on gene expression. The precise mode of action of these activators can vary, but the overarching goal is to increase the intrinsic activity of ZNF625 without disrupting the function of other zinc finger proteins or cellular components.
The discovery process for ZNF625 activators usually begins with a high-throughput screening of diverse chemical libraries to identify molecules that can potentially increase the activity of the ZNF625 protein. Following the identification of initial 'hit' compounds, these molecules are then validated through a series of secondary assays that are designed to ensure that the activatory effect is specific to ZNF625. This specificity is crucial to eliminate off-target effects that could lead to erroneous conclusions about the function of ZNF625. Once a select group of molecules has been confirmed as specific activators, they undergo a process of chemical optimization. This involves refining and modifying their chemical structure to enhance their potency, selectivity, and stability. Structural biology techniques such as X-ray crystallography or cryo-electron microscopy may be employed to determine the activator binding sites and to understand the molecular basis of the activation process. Computational chemistry tools, including molecular docking and virtual screening, are often utilized to predict how structural changes may impact the interaction with ZNF625 and guide rational design improvements. Through iterative cycles of design, synthesis, and biological testing, the most promising ZNF625 activators are developed, which can then serve as powerful tools for probing the biological functions of ZNF625 and its role in the complex network of gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May decrease DNA methylation globally, potentially affecting the expression of genes including ZNF625. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
As a histone deacetylase inhibitor, it can increase histone acetylation and potentially enhance ZNF625 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
It binds to GC-rich DNA sequences, potentially influencing the transcription of genes with similar promoter regions to ZNF625. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol found in green tea that may modulate gene expression and have epigenetic effects affecting ZNF625. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Known to modulate proteasome activity, which could indirectly affect the turnover and expression of numerous proteins, including ZNF625. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
Often used as a solvent in biological studies; it can also affect differentiation and gene expression patterns. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A histone deacetylase inhibitor that may increase the expression of various genes, potentially including ZNF625. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
A form of estrogen that can modulate gene expression through estrogen receptor signaling, potentially influencing ZNF625. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that can regulate gene expression through glucocorticoid receptor signaling, possibly affecting ZNF625. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
As a folate analog, it may alter DNA methylation and thus gene expression, potentially influencing ZNF625 expression. | ||||||